SCHEMBL6366236

SCHEMBL6366236

O=C(c1cccc(Cl)c1)c1cccc2c1C(=O)c1cccc(C(=O)c3cccc(Cl)c3)c1C2=O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PARP1 P09874 1/20 0.47
ALOX15 P16050 1/20 0.46
BDKRB1 P46663 1/20 0.45
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27584329 0.95 ALDH1A1 (0.55) ALDH1A1L3MBTL1PARP1ALOX15BDKRB1
SCHEMBL6366673 0.83 NR4A1 (0.54) ALDH1A1L3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL3446883 0.81 PARP1 (0.59) ALDH1A1L3MBTL1PARP1ALOX15BDKRB1
SCHEMBL6374034 0.79 RECQL (0.50) ALDH1A1L3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL28750153 0.79 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL308358 0.78 ALDH1A1 (0.71) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL3173817 0.76 PARP1 (0.68) ALDH1A1L3MBTL1PARP1ALOX15MAPT
SCHEMBL3179857 0.76 RECQL (0.57) ALDH1A1PARP1ALOX15BDKRB1MAPT
SCHEMBL27584330 0.76 ALDH1A1 (0.54) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL6341269 0.75 RECQL (0.60) ALDH1A1PARP1ALOX15MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM ALDH1A1 692/4885L3MBTL1 301/4885PARP1 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.